Please login to the form below

Not currently logged in
Email:
Password:

Boston Pharma appoints ex-Pfizer and Sanofi executives

Santiago Arroyo and Constantine Chinoporos join its senior team

Constantine ChinoporosBoston Pharmaceuticals has appointed Santiago Arroyo as chief medical officer and Constantine Chinoporos as chief business officer to further build and develop its portfolio.

The company is led by ex-Sanofi CEO Chris Viehbacher and one of Boston's new senior hires comes from the French pharma firm.

Chinoporos was previously vice president of global licensing and business development at Sanofi and has also served as vice president of corporate development at Genzyme and alliance manager or primary care product group at Lilly.

He said: “Boston Pharmaceuticals is intensely focused on efficient clinical development of new medicines and I look forward to helping build an extensive portfolio of new and novel products.

“This is an opportunity to leverage my extensive network of industry partners in identifying great licensing opportunities that can ultimately benefit patients.”

Santiago ArroyoMeanwhile, Arroyo (pictured left) arrives from Pfizer, where he was senior vice president and chief medical officer, having previously also held senior positions at Bristol-Myers Squibb and Eisai.

He said: “I am excited to be part of Boston Pharmaceuticals and to join the team creating a substantial portfolio of clinical programmes across important disease states to bring new medicine to patients.

“I look forward to partnering with biotechnology and biopharmaceutical companies in identifying and further developing potential new medicines.” 

27th November 2015

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Looking back at the year when everything changed
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....

Infographics